Beyond Earth’s Gravity: Navigating Legal Hurdles in Space-Based Drug Research and Development
Year: 2025
Type: article
Abstract: For over 20 years, scientists aboard the International Space Station (the “ISS”) have been expanding the boundaries of scientific knowledge. Leveraging microgravity and other extreme conditions unique to space, these scientists have made significant discoveries in cellular behavior, tissue engineering, gene expression, organism growth patterns, and regenerative medicine. This article aims to introduce the pharmaceutical and biotechnology communities to the exciting possibilities and challenges of conducting research and development (“R&D”) in space. The scientific advantages of space-based drug R&D are compelling. Experiments conducted aboard the ISS National Lab, along with ground-based studies, reveal unique features that cannot be replicated under normal gravity conditions. For instance, space-based drug research has shown that microgravity conditions enable more efficient 3D cell cultures, improved protein crystal growth, and open up new possibilities for 3D printing of biomaterials, cells, tissues, and organs.
Authors: Daniel García, Mike Druckman
Institution: Hogan Lovells (United States)
Language: English
Subfield: Astronomy and Astrophysics
Field: Physics and Astronomy
Domain: Physical Sciences
Open Access status: diamond
OpenAlex ID: W4407166360